Copy number variations of MMP-9 are prognostic biomarkers for hepatocellular carcinoma
نویسندگان
چکیده
منابع مشابه
Copy number variations and expression of MPDZ are prognostic biomarkers for clear cell renal cell carcinoma
The vital copy number variation (CNV) plays a crucial role in clear cell renal cell carcinoma (ccRCC). MPDZ inhibit cell polarity associate with osmotic pressure response and cancer-related biological processes. In order to clarify the role of the CNV of MPDZ in the progression of ccRCC, we analyzed the CNV and expression of MPDZ and prognosis in ccRCC patients from The Cancer Genome Atlas data...
متن کاملHeteroplasmy and Copy Number Variations of Mitochondria in 88 Hepatocellular Carcinoma Individuals
Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. In this study, we had analysed the copy number variations and heteroplasmic mutations of mitochondria (MT) in 88 HCC individuals. The average copy number of MT genome in normal samples was significantly greater than that in tumor samples. Overall, the number of heteroplasmic mutations in 88 tumor and their ...
متن کاملAre biomarkers still helpful in hepatocellular carcinoma?
surement and, in the case of detection of a suspicious focus of a certain size, additional radiological investigation by CT or MRI and, if HCC was confirmed by imaging or biopsy, a decision to treat. This surveillance-step combination was still maintained at the Asian Oncology Summit 2009 [3] , by the WGO guideline from 2010 [4] and was even extended by the Japanese Society of Hepatology, which...
متن کاملBiomarkers for Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The HCC diagnosis is usually achieved by biomarkers, which can also help in prognosis prediction. Furthermore, it might represent certain therapeutic interventions through some combinations of biomarkers. Here, we review on our current understanding of HCC biomarkers.
متن کاملBiomarkers for Hepatocellular Carcinoma
The hepatocellular carcinoma (HCC) is one of the most common malignant tumors and carries a poor survival rate. The management of patients at risk for developing HCC remains challenging. Increased understanding of cancer biology and technological advances have enabled identification of a multitude of pathological, genetic, and molecular events that drive hepatocarcinogenesis leading to discover...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Translational Cancer Research
سال: 2020
ISSN: 2218-676X,2219-6803
DOI: 10.21037/tcr.2019.11.52